Is CVE-2020-16247 actively exploited?

CVE-2020-16247 has no public evidence of in-the-wild exploitation as of 2025-06-04.

What is the CVSS score for CVE-2020-16247?

CVE-2020-16247 has a CVSS score of 6.8 (MEDIUM severity). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:H.

How do I patch CVE-2020-16247?

Patch guidance is available from philips security advisories. CVEDatabase generates AI-assisted remediation guidance on demand for CVE-2020-16247.

Which products are affected by CVE-2020-16247?

1 product: philips clinical collaboration platform.

CVE-2020-16247 - remediation guidance & executive summary

Description

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.

CVSS Metrics

Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:H
Attack Vector: local
Complexity: low
Privileges: none
User Action: none
Scope: unchanged
Confidentiality: none
Integrity: low
Availability: high
Weaknesses: CWE-16 CWE-668

Metadata

Primary Vendor: PHILIPS
Published: 9/18/2020
Last Modified: 6/4/2025
Source: NIST NVD
Note: Verify all details with official vendor sources before applying patches.

Affected Products

philips : clinical_collaboration_platform

Remediation Guidance

Executive Summary

Cite this page

CVE-2020-16247. CVEDatabase.com. Retrieved 1 May 2026. https://cvedatabase.com/cve/CVE-2020-16247

View on NIST NVD

CVE-2020-16247 vulnerability